April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Diego A. Díaz García: Cross-priming is key in cancer immunotherapy
Apr 2, 2025, 10:53

Diego A. Díaz García: Cross-priming is key in cancer immunotherapy

Diego A. Díaz García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology, shared an article by Carlos Luri-Rey, et al. on X:

Cross-priming is key in cancer immunotherapy.

  • cDC1s cross-present tumor antigens & activate CD8+ T cells.
  • Their abundance correlates with ICI response.
  • FLT3L-based therapies show promise in trials.”

Diego A. Díaz García: Cross-priming is key in cancer immunotherapy

Cross-priming in cancer immunology and immunotherapy.

Authors: Carlos Luri-Rey, et al.

Diego A. Díaz García: Cross-priming is key in cancer immunotherapy